Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Genentech lays off 103 alongside gRED rethink, pens $490M breast cancer collab

Genentech lays off 103 alongside gRED rethink, pens $490M breast cancer collab

July 5, 2026Posted inBiotechnology

A month after Genentech confirmed the restructuring of its early development group, the Roche subsidiary has now disclosed that this has formed part of a round of 103 layoffs.

Post navigation

Previous Post
quasi-bound-states-boost-quantum-well-photoresponse Quasi-Bound States Boost Quantum Well Photoresponse
Next Post
StockWatch: New UC Data Sparks Smoother Sailing for Abivax stockwatch:-new-uc-data-sparks-smoother-sailing-for-abivax

Recent Posts

  • KAIST develops semiconductor neuron that harnesses noise to selectively process signals
  • Imagining natural and extra robotic thumbs together strengthens kinesthetic sensorimotor networks
  • PARP1 Drives Neuropathic Pain Through GPX4-Dependent Ferroptosis in Injured Mice’s Sensory Neurons
  • Strubbelig–NHL3 Receptor Complex Helps Arabidopsis Respond to Cellulose Deficiency
  • Bombyx mori Satellitome Analysis Reveals Evolutionary Stability, Dispersed Chromosomal Organization, Transposon Origins

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top